Redhill Biopharma Ltd ADR buy Slovakia
Start price
12.03.22
/
100%
€1.62
Target price
12.03.23
€6.00
Performance (%)
-71.54%
End price
14.11.22
€0.46
Summary
This prediction ended on 14.11.22 with a price of €0.46. Massive losses of -71.54% were the result for the BUY prediction by Slovakia. Slovakia has 100% into this prediction This prediction was marked as speculative and is excluded from Slovakia's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Redhill Biopharma Ltd ADR | - | - | - |
| iShares Core DAX® | 0.238% | -2.265% | 13.679% |
| iShares Nasdaq 100 | -0.304% | 5.808% | 34.538% |
| iShares Nikkei 225® | 2.271% | 1.577% | 9.436% |
| iShares S&P 500 | -0.296% | 4.447% | 28.577% |
According to Slovakia what are the pros and cons of Redhill Biopharma Ltd ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Fair valuation
ROE higher than 10% per year
Good culture
Leading role in innovation
Growths much faster than the competition
Very differentiated customer and product portfolio
Top 10 in its market
Very Future proof/growth oriented business model
Cons
Below average Management
High risks for its business
Comments by Slovakia for this prediction
In the thread Redhill Biopharma Ltd ADR diskutieren
Buy Redhill Biopharma Ltd ADR
Kursziel gesetzt auf 6,0